GUD.TO
Knight Therapeutics Inc
Price:  
5.62 
CAD
Volume:  
27,100.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO WACC - Weighted Average Cost of Capital

The WACC of Knight Therapeutics Inc (GUD.TO) is 6.6%.

The Cost of Equity of Knight Therapeutics Inc (GUD.TO) is 6.45%.
The Cost of Debt of Knight Therapeutics Inc (GUD.TO) is 9.80%.

Range Selected
Cost of equity 5.50% - 7.40% 6.45%
Tax rate 22.30% - 26.90% 24.60%
Cost of debt 7.90% - 11.70% 9.80%
WACC 5.5% - 7.6% 6.6%
WACC

GUD.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.45 0.54
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 7.40%
Tax rate 22.30% 26.90%
Debt/Equity ratio 0.12 0.12
Cost of debt 7.90% 11.70%
After-tax WACC 5.5% 7.6%
Selected WACC 6.6%